University Hospital Toulouse
Toulouse, 31059, France
NCT Number: NCT02604121
Prospective study of diagnosis validation of a cytological technique. 200 patients with oral cavity cancerous and precancerous lesions will be enrolled.
A cytological sample of the lesion will be performed by transepithelial brushing ( Orcellex® Rovers brush) in cytology liquid-based technology (methode ThinPrep 2000 (Hologic®)). A microscopic double blind reading will be performed. A biopsy sampling will be carried out in accordance with current strategy of screening. The brushing diagnosis quality will be compared to the biopsy which is the gold standard.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Toulouse, 31059, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
transepithelial brushing
Time frame: baseline
Diagnostic validity (specificity and sensibility, the classification of lesions is performed according Bethesda system, 2001 and the reference is the histology of biopsy of lesion
Time frame: baseline
Calculation of predictive value (positive and negative) of cytology / the reference is histology of biopsy
Time frame: Baseline
sample rate not satisfactory= hemorrhage hiding the cells of interest
Time frame: Baseline
sample rate not satisfactory : low cellularity of the material
Time frame: Baseline
reproducibility intra and inter observers of cytology interpretation (kappa de cohen)
University Hospital, Toulouse
Other
Interest of Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity by Transepithelial Brushing in Liquid-based
Acronym: Cytobuccale
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06231537
Disease, Head and Neck Neoplasms
Rio de Janeiro, Brazil
View Trial DetailsNCT00341497
Head and Neck Neoplasms, Leukoplakia
San Francisco, California, United States
View Trial DetailsNCT04009811
Communication Disorders, Congenital Abnormalities
Bordeaux, France
View Trial DetailsNCT00721799
Head and Neck Neoplasms, Laryngeal Diseases
Iowa City, Iowa, United States
View Trial Details